TVTX Stock Analysis: Buy, Sell, or Hold?
TVTX - Travere Therapeutics, Inc. Common Stock
$56.29
-0.30 (-0.53%)
▼
5d:
-2.07%
30d:
+20.43%
90d:
+94.37%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 05, 2026
21d
Smart Money Accumulation
None View Scanner →
Strength: 5.6/10
Get Alerted When TVTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TVTX shows positive signals but monitor for confirmation. Market pricing in 0.9% decline. Moderate conviction.
💡 BUY OPPORTUNITY: TVTX shows positive signals but monitor for confirmation. Market pricing in 0.9% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$112.41
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$69.80
19.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TVTX is currently trading at $56.29, which is considered fair relative to its 30-day fair value range of $50.03 to $58.56. The stock's valuation (Forward PE: 11.6) is in line with its historical norms (11.9). Remarkably, the market is currently pricing in an annual earnings decline of 0.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TVTX is in a strong uptrend. Immediate support is located at $53.94, while resistance sits at $59.69.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TVTX is in a strong uptrend. Immediate support is located at $53.94, while resistance sits at $59.69.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$50.03 -
$58.56
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
67.6%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($58.36)
Trading Range Analysis
30-Day Trading Range
$50.03 -
$58.56
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$53.94
Resistance Level
$59.69
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.60
Wall Street Target
$58.36
(+3.7%)
Revenue Growth (YoY)
55.6%
Profit Margin
-4.0%
Valuation Discount vs History
-0.9% cheaper
PE vs Historical
11.6 vs 11.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.9%
(market-implied from PE analysis)
1-Year Target
$55.78
(-1%)
2-Year Target
$55.28
(-2%)
3-Year Target
$54.78
(-3%)
3-Yr Target (if PE normalizes)
(PE: 12→12)
$56.18
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 159.6%)
$356.56
(+533%)
Base:
(SPY PE: 11.6, Growth: 159.6%)
$189.98
(+238%)
Bear:
(PE: 9.9, Growth: 159.6%)
$161.48
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.6 to 11.9
Stabilization Target:
$57.72
(+2.5%)
PE Expansion Potential:
+2.5%
Share & Embed Analysis
Last updated: July 13, 2026 10:34 PM ET
Data refreshes hourly during market hours. Next update: 11:34 PM
Data refreshes hourly during market hours. Next update: 11:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TVTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
William E Rote
SELL
9100 shares
2026-04-22
Christopher R Cline
SELL
1014 shares
2026-04-15
Elizabeth E Reed
SELL
6785 shares
2026-04-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 62 BUY |
Advanced TVTX Option Strategies
Professional options setups generated by AI based on today's TVTX price and gamma walls.
